Tous Actualités
Suivre
Abonner LifeWatch AG

LifeWatch AG

EANS-Adhoc: LifeWatch announces the appointments of Dr. Andrea Natale and Dr. John F. Beshai to its Medical Advisory Board

  Ad-hoc-Mitteilung übermittelt durch euro adhoc mit dem Ziel einer
  europaweiten Verbreitung. Für den Inhalt ist der Emittent verantwortlich.
Forschung/Entwicklung/Medical Advisory Board
12.05.2009
Neuhausen am Rheinfall / Switzerland and Chicago / USA, May 12, 2009 
- Card Guard AG's (SIX Swiss Exchange: CARDG) American subsidiary 
LifeWatch Services, Inc., the leader in the provision of wireless 
telemedicine services in the U.S., announced that Andrea Natale, 
M.D., and  John F. Beshai, M.D., have joined the Company's Medical 
Advisory Board (MAB). The LifeWatch MAB is comprised of renowned 
physicians and researchers in the fields of cardiology and 
electro-physiology. In their capacity as MAB members Dr. Natale and 
Dr. Beshai will provide guidance and support in the development of 
LifeWatch's clinical strategy and patient care programs for Atrial 
Fibrillation and Syncope.
"We are extremely pleased and excited to have such esteemed 
colleagues become part of LifeWatch's Medical Advisory board", stated
Harry Kopelman, M.D., LifeWatch Medical Advisory Board Chairman. "Dr.
Beshai and Dr. Natale will accelerate our efforts and deepen our 
clinical expertise", he added.
Dr. Andrea Natale is a world renowned electrophysiologist and was the
first electrophysiologist in the U.S. to perform percutaneous 
epicardial radiofrequency ablation, which is a treatment for people 
who fail conventional ablation. Dr. Natale has served as director of 
the electrophysiology laboratory at Duke University, director of the 
electrophysiology program at the University of Kentucky, Lexington, 
and as a professor at prestigious universities, including Duke 
University and Stanford University. In addition to serving on the 
editorial boards of numerous medical journals, he is editor-in-chief 
of the Journal of Atrial Fibrillation. Dr. Natale graduated summa cum
laude from the Medical School of the University of Florence, Italy, 
and summa cum laude from the Catholic University School of Cardiology
in Rome, Italy. He received his clinical training in cardiology at 
Methodist Hospital, Baylor College in Houston and at the University 
of Western Ontario in London, Ontario, Canada. After completing a 
clinical fellowship in cardiology (electrophysiology) at the 
University of Western Ontario in 1991, he further trained in 
cardiology (electrophysiology) at the University of Wisconsin, Sinai 
Samaritan Medical Center in Milwaukee.
Dr. John Beshai serves as the Director of Pacemaker and Defibrillator
Services at the University of Chicago, and is an Assistant Professor 
of Medicine at the University of Chicago's Pritzker School of 
Medicine. Dr. Beshai has served as an Assistant Professor of Medicine
at the Emory University School of Medicine He completed his 
fellowships in Clinical Cardiac Electrophysiology and Cardiovascular 
Medicine from the Hospital of the University of Pennsylvania, and has
a fellowship in Cardiovascular Medicine from the New England Medical 
Center at Tufts University School of Medicine in Boston. Dr. Beshai 
completed his undergraduate degree at The Ohio State University 
followed by his Medical Degree at St. George's University in 1996. He
served as National P.I. and Steering Committee Chairman for the 
Resynchronization Therapy in Patients with Heart Failure and Narrow 
QRS (RETHINQ).  In addition, he serves as a peer reviewer for 
numerous journals including JCE, HRS, and AJC.
LifeWatch Medical Advisory Board:
Harry Kopelman, M.D. - Atlanta, GA
Dr. Kopelman is Co-Director of Electrophysiology Research and 
affiliate Scientist at the Piedmont Heart Institute where he has 
played a central role in the program's development an in ongoing 
clinical and pre-clinical research.
John F. Beshai, M.D., F.A.C.C., F.H.R.S. - Chicago, IL
Dr. John Beshai serves as the Director of Pacemaker and Defibrillator
Services at the University of Chicago, and is an Assistant Professor 
of Medicine at the University of Chicago's Pritzker School of 
Medicine
Alan Kadish, M.D., F.A.C.C., F.H.R.S - Evanston, IL
Dr. Kadish is a fellow of both the American College of Cardiology and
the American Heart Association, and sits on the editorial board or is
an Editorial Consultant for more than a dozen cardiology journals. 
Dr. Kadish serves as Senior Associate Chief of Cardiology at 
Northwestern Memorial Hospital.
Andrea Natale, M.D., F.A.C.C., F.H.R.S. - San Francisco, CA
Dr. Natale is the Senior Medical Director of the California Pacific 
Medical Center for Atrial Fibrillation and Arrhythmia Program in San 
Francisco, CA. In addition to serving on the editorial boards of 
numerous medical journals, he is editor-in-chief of the Journal of 
Atrial Fibrillation. Biography of Dr. Andrea Natale
James Reiffel, M.D. F.A.C.C., F.H.R.S - NYC, NY
Dr. Reiffel is a Professor of Clinical Medicine, Columbia University 
College of Physicians and Surgeons; Attending Physician, Columbia 
Presbyterian Medical Center Campus.
Steve Prater, M.D. - Atlanta, GA
Dr. Prater is a board certified cardiologist and electrophysiologist.
Dr. Prater completed his Electrophysiology fellowship at Loyola 
University of Chicago, and is currently a practicing 
Electrophysiologist at the Piedmont Heart Institute.
About Card Guard AG
Card Guard AG, headquartered in Neuhausen am Rheinfall, Switzerland, 
is a leading healthcare technology and solution company, specializing
in advanced telehealth systems and wireless cardiac monitoring 
services. Card Guard services treat high-risk and chronically ill 
patients, health conscious consumers and wellness programs. Card 
Guard has subsidiaries in the United States, the Netherlands, Japan, 
the United Kingdom, Switzerland and Israel. Card Guard AG is the 
parent company of LifeWatch Services Inc., a leading US- based 
cardiac monitoring service provider, and LifeWatch Technologies Inc.,
a US-based manufacturer of telecardiology products. www.cardguard.com
About LifeWatch Corp.
LifeWatch is a wholly owned subsidiary of Card Guard AG, a leading 
healthcare technology and solutions provider listed on SIX Swiss 
Stock Exchange (CARDG). LifeWatch Corp., through its operating 
subsidiaries LifeWatch Services, Inc. and LifeWatch Technologies, 
Inc. (Instromedix) is an independent provider of ambulatory cardiac 
monitoring services and a manufacturer and distributor of ambulatory 
cardiac and vital signs monitoring devices in the United States. Its 
current services are used by physicians primarily to monitor patients
who are suspected of having heart rhythm disorders, or cardiac 
arrhythmias, and its products are used by itself and by others in 
connection with providing cardiac monitoring services. For more 
information, visit: www.lifewatch.com.
Upcoming Card Guard Events
18 May 2009      Analysts' and Media conference Results Q1 2009
26 May 2009      Annual Shareholder Meeting of Card Guard AG in 
Zurich
This press release includes forward-looking statements. All 
statements other than statements of historical facts contained in 
this press release, including statements regarding future results of 
operations and financial position, business strategy and plans and 
objectives for future operations, are forward- looking statements. 
The words "believe," "may," "will," "estimate," "continue," 
"anticipate," "intend," "expect" and similar expressions are intended
to identify forward-looking statements. Card Guard AG has based these
forward- looking statements largely on current expectations and 
projections about future events and financial trends that it believes
may affect the financial condition, results of operations, business 
strategy, short term and long term business operations and 
objectives, and financial needs. These forward-looking statements are
subject to a number of risks, uncertainties and assumptions. In light
of these risks, uncertainties and assumptions, the forward-looking 
events and circumstances described may not occur and actual results 
could differ materially and adversely from those anticipated or 
implied in the forward- looking statements. All forward-looking 
statements are based only on data available to Card Guard AG at the 
time of the issue of this press release. Card Guard AG does not 
undertake any obligation to update any forward-looking statements 
contained in this press release as a result of new information, 
future events or otherwise.
THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF 
AMERICA AND SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR 
PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES.  THIS 
PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF CARD 
GUARD AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES OR 
AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF CARD 
GUARD AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE 
SECURITIES OF CARD GUARD AG AND ITS SUBSIDIARIES HAVE NOT BEEN 
REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE 
OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S. 
PERSONS ABSENT REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE
REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS.  ANY 
PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED STATES WILL BE
MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM CARD GUARD AG
OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED 
INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL 
STATEMENTS OF THE ISSUER.

Rückfragehinweis:

Kobi Ben Efraim
Chief Financial Officer
Tel +41 52 632 00 50 | Fax +41 52 632 00 51

Email kobibe@cardguard.com

Sensus Investor and Public Relations GmbH, Zürich:
Tel +41 43 366 55 11 | Fax +41 43 366 55 12
Email cardguard@sensus.ch

Branche: Gesundheitsdienste
ISIN: CH0012815459
WKN: 1281545
Index: SPI, SPIEX
Börsen: Frankfurt / Open Market (Freiverkehr) / XETRA
SIX Swiss Exchange / Hauptsegment
Berlin / Freiverkehr

Plus de actualités: LifeWatch AG
Plus de actualités: LifeWatch AG